Enigma Diagnostics Exclusively Licenses UK Defense Lab IP Supporting RT-PCR Systems | GenomeWeb
NEW YORK (GenomeWeb News) — Enigma Diagnostics yesterday said it has licensed a “broad range” of technologies from the UK’s Defense Science and Technology Laboratory that will give the company “much greater control” over IP “at the heart” of its real-time PCR systems.
 
The worldwide exclusive license covers 25 DSTL patents and patent applications. In particular, the license covers the Pyrostart, ResonSense, and Temperature Control, technologies, which Enigma called “important elements” of its RT-PCR systems.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.